| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d90ed9831bf66e07609255e3af783473 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1617
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4858
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4866
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4166
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1641
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1635
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1652
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1623 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4164 |
| filingDate |
2020-01-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_991fb400808c4b0328d1048e3ffe5a62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a6c19fcd30016009f4caccd3ce027e3b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_67b03c809ccbb891541fabbea04473b9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b6227a47468f4823aab586cce2d53540
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d5de16c23fb36acd5ca8e79333c193e3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3aa907676490128c449451b7f559118b |
| publicationDate |
2020-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CL-2020000017-A1 |
| titleOfInvention |
Novel composition of enzalutamide oral dosage form and its method of manufacture. |
| abstract |
THE PRESENT INVENTION REFERS TO A NOVEL COMPOSITION OF ORAL DOSAGE FORMS OF ENZALUTAMIDE WITH PHARMACEUTICALLY ACCEPTABLE EXCIPIENTS AND TO THE MANUFACTURING METHOD OF THE SAME. THE INVENTION PROVIDES AN ADVANCED AND ECONOMIC DOSAGE FORM. |
| priorityDate |
2017-07-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |